Oncology

A study on online adaptive radiotherapy reveals reduced treatment margins and lower radiation doses to organs at risk in gastric MALT lymphoma patients

A history of paediatric cancer has been linked to long-term cognitive challenges after treatment, affecting areas such as working memory and processing speed.

A groundbreaking clinical trial testing QH104, an allogeneic B7H3-targeting CAR-γδT cell therapy, has shown promising results for patients with recurrent glioblastoma.

A new study provides the first evidence that breastfeeding is safe for women with BRCA mutations after breast cancer treatment.

Results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study have been presented at ESMO 2024, Barcelona, Spain

The PEACE-3 trial shows that combining Enzalutamide with Radium-223 improves progression-free survival in metastatic castration-resistant prostate cancer.

New clinical trial results, presented at ESMO 2024, show that an investigational mRNA-based vaccine CVGBM is safe and well-tolerated in patient with newly diagnosed MGMT-unmethylated glioblastoma (GBM).

Researchers have made a significant breakthrough in understanding ductal carcinoma in situ, a pre-invasive tumour that can progress to invasive breast cancer.